The diagnosis and prognosis of autosomal dominant polycystic kidney disease.

PubWeight™: 2.26‹?› | Rank: Top 2%

🔗 View Article (PMID 2215575)

Published in N Engl J Med on October 18, 1990

Authors

P S Parfrey1, J C Bear, J Morgan, B C Cramer, P J McManamon, M H Gault, D N Churchill, M Singh, R Hewitt, S Somlo

Author Affiliations

1: Department of Medicine, Memorial University of Newfoundland, St. John's, Canada.

Articles citing this

Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol (2008) 4.07

Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat Rev Nephrol (2010) 1.63

The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol (2010) 1.59

Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet (2001) 1.47

MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clin J Am Soc Nephrol (2009) 1.24

Adult polycystic kidney disease: a disorder of connective tissue? Int J Clin Exp Pathol (2008) 1.11

Linkage disequilibrium in the region of the autosomal dominant polycystic kidney disease gene (PKD1). Am J Hum Genet (1994) 1.11

Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease. J Med Genet (1998) 1.10

A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am J Hum Genet (1997) 1.04

Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies. Cell Mol Life Sci (2008) 1.01

Diagnosis and screening of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis (2010) 0.99

Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol (2010) 0.99

A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2. Am J Hum Genet (1999) 0.99

Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol Med (1996) 0.99

Prognosis of autosomal dominant polycystic kidney disease diagnosed in utero or at birth. Pediatr Nephrol (2006) 0.95

Pkd1 and Pkd2 are required for normal placental development. PLoS One (2010) 0.94

Hand-assisted laparoscopic nephrectomy for polycystic kidney disease. JSLS (2013) 0.93

Genetic variation of DKK3 may modify renal disease severity in ADPKD. J Am Soc Nephrol (2010) 0.91

DNA microsatellite analysis of families with autosomal dominant polycystic kidney disease types 1 and 2: evaluation of clinical heterogeneity between both forms of the disease. J Med Genet (1995) 0.89

Polycystic Kidney Disease with Renal failure Presenting as Incarcerated Inguinal Hernia in the ED. West J Emerg Med (2009) 0.89

Phenotype recognition. Clinicians' contributions to molecular genetics. West J Med (1992) 0.88

Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells. Am J Physiol Renal Physiol (2012) 0.84

Estimating locus heterogeneity in autosomal dominant polycystic kidney disease (ADPKD) in the Spanish population. J Med Genet (1993) 0.83

Case report of renal pelvis squamous cell carcinoma with tumor embolus in autosomal dominant polycystic kidney disease. Medicine (Baltimore) (2016) 0.82

Genetic and clinical studies in autosomal dominant polycystic kidney disease type 1 (ADPKD1). J Med Genet (1992) 0.82

Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1. Hum Mol Genet (2012) 0.81

Laparoscopic pretransplant nephrectomy with morcellation in autosomic-dominant polycystic kidney disease patients with end-stage renal disease. Surg Endosc (2014) 0.81

Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register. J Med Genet (1994) 0.80

Four-dimensional MRI of renal function in the developing mouse. NMR Biomed (2014) 0.79

Renal-hepatic-pancreatic dysplasia: an autosomal recessive malformation. J Med Genet (1996) 0.79

Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models. Hered Cancer Clin Pract (2009) 0.78

PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease. BMC Med Genet (2006) 0.77

Haplotype analysis in autosomal dominant polycystic kidney disease. J Med Genet (1995) 0.75

Genetic heterogeneity of autosomal dominant polycystic kidney disease in Argentina. J Med Genet (1997) 0.75

Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report. J Med Case Rep (2012) 0.75

A family with autosomal dominant polycystic kidney disease linked to 4q21-23. J Med Genet (1995) 0.75

Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization. J Am Soc Nephrol (2015) 0.75

Pravastatin Therapy and Biomarker Changes in Children and Young Adults with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol (2015) 0.75

Genetic heterogeneity and clinical disease. West J Med (1992) 0.75

Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report. Exp Ther Med (2017) 0.75

Articles by these authors

Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02

Rapid synthesis of oligodeoxyribonucleotides VI. Efficient, mechanised synthesis of heptadecadeoxyribonucleotides by an improved solid phase phosphotriester route. Nucleic Acids Res (1981) 11.77

Rapid synthesis of oligodeoxyribonucleotides. IV. Improved solid phase synthesis of oligodeoxyribonucleotides through phosphotriester intermediates. Nucleic Acids Res (1980) 7.01

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05

Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A (1989) 5.03

HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell (1990) 4.50

The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41

Rapid synthesis of oligodeoxyribonucleotides. VII. Solid phase synthesis of oligodeoxyribonucleotides by a continuous flow phosphotriester method on a kieselguhr-polyamide support. Nucleic Acids Res (1982) 3.95

HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J (1990) 3.92

Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell (1998) 3.84

Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg Am (1970) 3.68

PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet (1997) 3.58

A critical period for macromolecular synthesis in long-term heterosynaptic facilitation in Aplysia. Science (1986) 3.30

Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol (2001) 3.26

A pathological and mineralogical study of asbestos-related deaths in the United Kingdom in 1977. Ann Occup Hyg (1982) 3.00

Rapid synthesis of oligodeoxyribonucleotides. V. Further studies in solid phase synthesis of oligodeoxyribonucleotides through phosphotriester intermediates. Nucleic Acids Symp Ser (1980) 2.94

Indications for cholesterol-lowering medication: comparison of risk-assessment methods. Lancet (1999) 2.75

Who is speaking for children and adolescents and for their health at the policy level? BMJ (2000) 2.75

Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem (1999) 2.74

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med (1989) 2.74

Getting a foothold in nephrotic syndrome. Nat Genet (2000) 2.68

Molecular cloning and expression of a human B-cell growth factor gene in Escherichia coli. Science (1987) 2.65

Dependence of the putrescine content of Escherichia coli on the osmotic strength of the medium. J Biol Chem (1972) 2.64

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A (1994) 2.58

Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci U S A (2000) 2.58

Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int (1997) 2.54

Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Thorax (1996) 2.54

Intestinal malrotation in adults. Indian J Gastroenterol (1991) 2.47

The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N Engl J Med (1988) 2.36

Biotransformation of dehydroabietic acid with resting cell suspensions and calcium alginate-immobilized cells of Mortierella isabellina. Appl Environ Microbiol (1985) 2.27

A multi-antigen print immunoassay for the development of serological diagnosis of infectious diseases. J Immunol Methods (2000) 2.24

Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet (2000) 2.24

Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. Proc Natl Acad Sci U S A (1991) 2.19

Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling. Am J Med Genet (1984) 2.10

Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat Med (2001) 2.08

A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology (2008) 2.07

Hydrogen peroxide fogging in an overcrowded tertiary care referral centre: some practical queries. J Hosp Infect (2005) 2.06

Intracuff pressure comparison between ProSeal(®) and Supreme(®) laryngeal mask airways. Anaesthesia (2013) 2.02

Use of a peripheral nerve stimulator for predicting caudal epidural analgesia. Anaesthesia (2000) 2.02

Uranium concentration in groundwater in Hisar city, India. Int J Occup Environ Med (2014) 1.99

Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol (1996) 1.89

An electronically collimated gamma camera for single photon emission computed tomography. Part I: Theoretical considerations and design criteria. Med Phys (1983) 1.86

Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics (1995) 1.86

Quality parameters of mango and potential of non-destructive techniques for their measurement - a review. J Food Sci Technol (2010) 1.85

Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet (1998) 1.85

Production of selenomethionine-labelled proteins using simplified culture conditions and generally applicable host/vector systems. Appl Microbiol Biotechnol (2001) 1.83

Syndrome associated with the abuse of analgesics. Ann Intern Med (1968) 1.82

Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ (2000) 1.80

Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment. BJU Int (2000) 1.79

Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics (1993) 1.77

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol (2008) 1.77

A randomised controlled study of close monitoring of vulnerable psychiatric patients. Lancet (1995) 1.76

Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol (1997) 1.76

A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates. Indian Pediatr (2000) 1.74

Price of prostatectomy. Br Med J (1974) 1.74

The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins? Microbiology (1999) 1.73

Salience of visual parts. Cognition (1997) 1.73

Tendon ruptures in patients with systemic lupus erythematosus treated with corticosteroids. Arthritis Rheum (1975) 1.72

The role of feedback in the process of health behavior change. Am J Health Behav (2001) 1.72

Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69

Bone-seeking radionuclides: an in vivo study of factors affecting skeletal uptake. Radiology (1974) 1.69

Biochemical separation of a human B cell mitogenic factor. Proc Natl Acad Sci U S A (1982) 1.68

A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int (1995) 1.68

A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression. J Mol Biol (1994) 1.67

Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest (2001) 1.66

Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models. Open Biol (2012) 1.65

Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64

Bilateral rhegmatogenous retinal detachment secondary to retinal dialyses associated with multiple retinal breaks. Eye (Lond) (2004) 1.64

Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med (1995) 1.63

Nerve growth cones isolated from fetal rat brain: subcellular fractionation and characterization. Cell (1983) 1.62

Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol (2000) 1.62

Purification of human B cell growth factor. J Immunol (1985) 1.61

Branch breakage under snow and ice loads. Tree Physiol (1989) 1.61

Continuities between psychiatric disorders in adolescents and personality disorders in young adults. Am J Psychiatry (1995) 1.61

Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology (2003) 1.61

APOE distribution in world populations with new data from India and the UK. Ann Hum Biol (2006) 1.59

Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis (1995) 1.59

Serodiagnosis of melioidosis in Singapore by the indirect haemagglutination test. Singapore Med J (1991) 1.59

Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci (2003) 1.59

Chemical warfare agents. Environ Toxicol Pharmacol (2008) 1.58

Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology (1991) 1.57

Reorientation of chromosome replication after exposure to ultraviolet light of Escherichia coli. J Mol Biol (1965) 1.57

Systematic review concerning the age of introduction of complementary foods to the healthy full-term infant. Eur J Clin Nutr (2001) 1.57

A hydrophobic sequence motif common to N-hydroxylating enzymes. Trends Biochem Sci (1998) 1.57

Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ (1997) 1.57

X-ray-induced perturbations in the replication of the bacterial chromosome. Biochim Biophys Acta (1965) 1.57

Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues. Proc Natl Acad Sci U S A (1982) 1.56

Genetic diversity in European and Mediterranean faba bean germ plasm revealed by RAPD markers. Theor Appl Genet (1995) 1.55

Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet (2010) 1.55

Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med (1987) 1.53

Uterine artery embolization: the role in obstetrics and gynecology. Clin Imaging (2001) 1.53

Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol (1999) 1.53

Impact of education and training on neonatal resuscitation practices in 14 teaching hospitals in India. Ann Trop Paediatr (2001) 1.53

A Study of Frequency-Dependent Selection Observed in the Esterase-6 Locus of DROSOPHILA MELANOGASTER Using a Conditioned Media Method. Genetics (1971) 1.52

Slowly fading super-luminous supernovae that are not pair-instability explosions. Nature (2013) 1.52